M&A / Deals Merck buys life sciences firm Bio-Techne in $11.3bn deal PharmaphorumMerck KGaA is poised to increase the size of its life sciences business with an $11.3 billion deal to acquire rival Bio-techne.Read full story pharminent June 25, 2026 (Last updated: June 26, 2026) Pharmaphorum Merck KGaA is poised to increase the size of its life sciences business with an $11.3 billion deal to acquire rival Bio-techne. Read full story Post navigation Previous: Ionis secures market expansion for Tryngolza as FDA clears severe hypertriglyceridemia useNext: Ionis grants Recordati rights to zilganersen for Alexander disease Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026